Susquehanna International Group, LLP Rani Therapeutics Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 16,554 shares of RANI stock, worth $8,277. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,554
Previous 40,700
59.33%
Holding current value
$8,277
Previous $55,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RANI
# of Institutions
44Shares Held
3.47MCall Options Held
44.3KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA800KShares$399,8390.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$246,7920.6% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$224,2460.05% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$151,3710.01% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$98,1080.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $12.2M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...